1. Home
  2. PHAR vs GRPN Comparison

PHAR vs GRPN Comparison

Compare PHAR & GRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • GRPN
  • Stock Information
  • Founded
  • PHAR 1988
  • GRPN 2008
  • Country
  • PHAR Netherlands
  • GRPN United States
  • Employees
  • PHAR N/A
  • GRPN N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • GRPN Advertising
  • Sector
  • PHAR Health Care
  • GRPN Consumer Discretionary
  • Exchange
  • PHAR Nasdaq
  • GRPN Nasdaq
  • Market Cap
  • PHAR 624.1M
  • GRPN 534.1M
  • IPO Year
  • PHAR N/A
  • GRPN 2011
  • Fundamental
  • Price
  • PHAR $8.86
  • GRPN $12.38
  • Analyst Decision
  • PHAR Strong Buy
  • GRPN Hold
  • Analyst Count
  • PHAR 3
  • GRPN 3
  • Target Price
  • PHAR $27.00
  • GRPN $17.00
  • AVG Volume (30 Days)
  • PHAR 5.9K
  • GRPN 801.3K
  • Earning Date
  • PHAR 03-13-2025
  • GRPN 03-14-2025
  • Dividend Yield
  • PHAR N/A
  • GRPN N/A
  • EPS Growth
  • PHAR N/A
  • GRPN N/A
  • EPS
  • PHAR N/A
  • GRPN 0.52
  • Revenue
  • PHAR $285,745,000.00
  • GRPN $499,894,000.00
  • Revenue This Year
  • PHAR $20.08
  • GRPN N/A
  • Revenue Next Year
  • PHAR $9.22
  • GRPN $0.32
  • P/E Ratio
  • PHAR N/A
  • GRPN $23.84
  • Revenue Growth
  • PHAR 30.64
  • GRPN N/A
  • 52 Week Low
  • PHAR $6.65
  • GRPN $7.75
  • 52 Week High
  • PHAR $12.20
  • GRPN $19.56
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 48.50
  • GRPN 56.40
  • Support Level
  • PHAR $8.50
  • GRPN $11.30
  • Resistance Level
  • PHAR $9.50
  • GRPN $13.82
  • Average True Range (ATR)
  • PHAR 0.56
  • GRPN 0.66
  • MACD
  • PHAR 0.03
  • GRPN 0.16
  • Stochastic Oscillator
  • PHAR 58.71
  • GRPN 61.50

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering a variety of products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

Share on Social Networks: